8 Cathie Wood 10x Genomics- Class A Trades
Cathie Wood's position in 10x Genomics- Class A is currently worth $168 Million. That's 1.01% of their equity portfolio (27th largest holding). The investor owns 3.86% of the outstanding 10x Genomics- Class A stock. The first 10x Genomics- Class A trade was made in Q2 2020. Since then Cathie Wood bought shares four more times and sold shares on three occasions. The investor's estimated purchase price is $522 Million, resulting in a loss of 68%.
Avg closing price
Price range
Increased shares by 27.5% (+730 Thousand shares)
Q1 2022
Avg closing price
$87.48
Price range
$55.70
-
$145.79
Sold 14.2% shares (-441 Thousand shares)
Q4 2021
Avg closing price
$153.17
Price range
$135.05
-
$182.59
Sold 27.9% shares (-1.2 Million shares)
Q3 2021
Avg closing price
$171.69
Price range
$145.58
-
$192.14
Increased shares by 22.7% (+796 Thousand shares)
Q2 2021
Avg closing price
$180.98
Price range
$134.22
-
$202.37
Increased shares by 556.8% (+2.97 Million shares)
Q1 2021
Avg closing price
$172.69
Price range
$140.25
-
$196.86
Increased shares by 130.9% (+302 Thousand shares)
Q4 2020
Avg closing price
$145.11
Price range
$126.47
-
$163.70
Sold 31.3% shares (-105 Thousand shares)
Q3 2020
Avg closing price
$104.97
Price range
$87.44
-
$125.00
New holding (+337 Thousand shares)
Q2 2020
Avg closing price
$77.89
Price range
$58.39
-
$89.31
